Institutional Ownership Tarsus Pharmaceuticals, Inc. (TARS)
This table provides information about the institutional ownership of Tarsus Pharmaceuticals, Inc. (TARS). We have compiled data on the 201 institutions that hold shares in the stock, with a total of 44.5 Million shares, which have been reported (via 13F filing form) to have a value of $1.79 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Rtw Investments, LP
New York, NY |
May 15, 2025 Q1 2025 |
3,316,032
shares
|
$133 Million
2.79% of portfolio
|
Q1 2025
Added 2.46%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,266,714
shares
|
$131 Million
0.0% of portfolio
|
Q2 2024
Added 23.15%
|
|
Paradigm Biocapital Advisors LP
New York, NY |
May 15, 2025 Q1 2025 |
2,610,197
shares
|
$105 Million
6.87% of portfolio
|
Q1 2025
Added 3.09%
|
|
Jennison Associates LLC
|
May 02, 2025 Q1 2025 |
2,492,640
shares
|
$100 Million
0.09% of portfolio
|
Q1 2025
Reduced 0.3%
|
|
Tang Capital Management LLC
San Diego, CA |
May 15, 2025 Q1 2025 |
2,454,797
shares
|
$98.6 Million
8.19% of portfolio
|
Q1 2025
Added 8.87%
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
2,226,595
shares
|
$89.4 Million
0.0% of portfolio
|
Q1 2025
Added 5.27%
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
2,012,777
shares
|
$80.8 Million
0.01% of portfolio
|
Q1 2025
Added 2.22%
|
|
Toronto Dominion Bank
Toronto, Ontario, A6 |
May 15, 2025 Q1 2025 |
1,874,745
shares
|
$75.3 Million
0.19% of portfolio
|
Q1 2025
Reduced 1.81%
|
|
Deep Track Capital, LP
Greenwich, CT |
May 15, 2025 Q1 2025 |
1,484,266
shares
|
$59.6 Million
2.67% of portfolio
|
Q1 2025
New holding
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
May 15, 2025 Q1 2025 |
1,397,527
shares
|
$56.1 Million
4.52% of portfolio
|
Q1 2025
Reduced 11.97%
|
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
May 13, 2025 Q1 2025 |
1,331,701
shares
|
$53.5 Million
0.24% of portfolio
|
Q1 2025
Added 4.04%
|
|
Assenagon Asset Management S.A.
|
Apr 15, 2025 Q1 2025 |
1,125,305
shares
|
$45.2 Million
0.11% of portfolio
|
Q1 2025
Reduced 1.88%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
992,642
shares
|
$39.9 Million
0.01% of portfolio
|
Q1 2025
Added 1151.11%
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
910,716
shares
|
$36.6 Million
0.0% of portfolio
|
Q1 2025
Reduced 0.67%
|
|
Macquarie Group LTD
Australia, C3 |
May 15, 2025 Q1 2025 |
892,781
shares
|
$35.9 Million
0.06% of portfolio
|
Q1 2025
Added 9.42%
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
865,434
shares
|
$34.8 Million
0.0% of portfolio
|
Q1 2025
Added 3.17%
|
|
Invesco Ltd.
Atlanta, GA |
May 12, 2025 Q1 2025 |
826,523
shares
|
$33.2 Million
0.01% of portfolio
|
Q1 2025
Reduced 11.33%
|
|
Driehaus Capital Management LLC
Chicago, IL |
May 15, 2025 Q1 2025 |
717,853
shares
|
$28.8 Million
0.4% of portfolio
|
Q1 2025
New holding
|
|
Orbimed Advisors LLC
San Diego, CA |
May 15, 2025 Q1 2025 |
653,743
shares
|
$26.3 Million
1.05% of portfolio
|
Q1 2025
New holding
|
|
Artisan Partners Limited Partnership
Milwaukee, WI |
May 14, 2025 Q1 2025 |
603,214
shares
|
$24.2 Million
0.05% of portfolio
|
Q1 2025
Reduced 12.74%
|
|
Janus Henderson Group PLC
London, X0 |
May 15, 2025 Q1 2025 |
512,960
shares
|
$20.6 Million
0.02% of portfolio
|
Q1 2025
Added 4009.6%
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
May 15, 2025 Q1 2025 |
510,000
shares
|
$20.5 Million
0.05% of portfolio
|
Q1 2025
New holding
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
May 14, 2025 Q1 2025 |
487,310
shares
|
$19.6 Million
0.05% of portfolio
|
Q1 2025
Reduced 14.52%
|
|
Ikarian Capital, LLC
Dallas, TX |
May 15, 2025 Q1 2025 |
485,021
shares
|
$19.5 Million
3.49% of portfolio
|
Q1 2025
Reduced 20.19%
|
|
Jefferies Group LLC
New York, NY |
Sep 21, 2023 Q3 2022 |
445,758
shares
|
$17.9 Million
0.07% of portfolio
|
Q3 2022
Added 10.68%
|